NFKB1 and cancer: TGF-β controls oxidative stress by both increasing ROS production and controlling the antioxidative system, whereas ROS controls Smad signaling, promoting the resistance of the cancer cells to the TGF-β-mediated inhibition of proliferation [77] in the initial stage of cancer, conflicting with the upregulation of the MAPK and NF-κB pathways.